Takeda Pharmaceutical (TAK) EBT Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) EBT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.50 Bn | 29.82 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.75 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.08 Bn | 7.43 Bn | 397.90 Mn | -101.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.93% |
| Mar 31, 2026 | 5.10% |
| Dec 31, 2025 | -318.90% |
| Sep 30, 2025 | 12.09% |
| Jun 30, 2025 | 18.63% |
| Mar 31, 2025 | 7.09% |
| Dec 31, 2024 | -317.80% |
| Sep 30, 2024 | -16.44% |
| Jun 30, 2024 | -10.94% |
| Mar 31, 2024 | -21.59% |
| Dec 31, 2023 | -57.27% |
| Sep 30, 2023 | 384.77% |
| Jun 30, 2023 | -18.04% |
| Mar 31, 2023 | -38.74% |
| Dec 31, 2022 | 19.42% |
| Sep 30, 2022 | -16.27% |
| Jun 30, 2022 | -40.98% |
| Mar 31, 2022 | 55.19% |
| Dec 31, 2021 | -39.56% |
| Sep 30, 2021 | 1,353.07% |